Adia Med ADIA
OTC ADIA
$0.13 +0.01 (+8.33%)
At close: Nov 10, 2026 · 4:00 PM EST

Adia Med (ADIA) Income from Continuing Operations (2025 - 2026)

Updated

Adia Nutrition's Income from Continuing Operations came in at -$162,525 for Q1 2026, compared with -$116,219 a year earlier.

Analysis

Adia Med (ADIA) Income from Continuing Operations (2025 - 2026) Analysis & Trends

For FY2025, Adia Nutrition's Income from Continuing Operations was -$395,464.

  • Going back by year, Income from Continuing Operations was -$181,067 in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 6.45 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 210.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 4.22 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 5.07 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 4.80 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 3.86 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 2.43 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 3.25 Bn
10 Adia Med 12.27 Mn 11.92 Mn 282,580.00 40,418.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 40,418.00
Mar 31, 2026 -162,525.00
Jun 30, 2025 -123,997.00
Mar 31, 2025 -116,219.00
API Access

Adia Med Income from Continuing Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=ADIA&period=max&api_key=YOUR_API_KEY